ID: ALA4073170

Max Phase: Preclinical

Molecular Formula: C27H19Cl2N5O2S2

Molecular Weight: 580.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccccc1NC(=S)NC(=O)c1ccc(CSc2nc(-c3ccc(Cl)cc3Cl)c(C#N)c(=O)[nH]2)cc1

Standard InChI:  InChI=1S/C27H19Cl2N5O2S2/c1-15-4-2-3-5-22(15)31-26(37)33-24(35)17-8-6-16(7-9-17)14-38-27-32-23(20(13-30)25(36)34-27)19-11-10-18(28)12-21(19)29/h2-12H,14H2,1H3,(H,32,34,36)(H2,31,33,35,37)

Standard InChI Key:  OXVFXKXYHOOBGW-UHFFFAOYSA-N

Associated Targets(non-human)

Bacillus amyloliquefaciens 102 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 580.52Molecular Weight (Monoisotopic): 579.0357AlogP: 6.34#Rotatable Bonds: 6
Polar Surface Area: 110.67Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.00CX Basic pKa: CX LogP: 6.95CX LogD: 6.52
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.14Np Likeness Score: -2.22

References

1. Cui P, Li X, Zhu M, Wang B, Liu J, Chen H..  (2017)  Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors.,  27  (10): [PMID:28041832] [10.1016/j.bmcl.2016.11.060]

Source